Arabic Arabic English English French French German German
dark

Muna Therapeutics Raises $73 Million to Advance Neurodegenerative Disease Focus

The company launches with the new funding to advance its focus on first-in-class small molecule therapies for neurodegenerative diseases. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Effect of yoga and physiotherapy on pulmonary functions in children with Duchenne muscular dystrophy.

Next Post

BeiGene Announces the Approval in China of KYPROLIS® (Carfilzomib) for Injection for Adult Patients with Relapsed or Refractory Multiple Myeloma

Related Posts
Total
0
Share